久立特材(002318.SZ):久立集團累計增持1133.49萬股 增持計劃已實施完畢
格隆匯 12 月 7日丨久立特材(002318.SZ)公佈,2020年12月4日,公司收到久立集團通知,此次增持計劃已實施完畢。久立集團自2020年5月26日至2020年6月4日期間通過深圳證券交易所集中競價交易方式增持公司股份841.54萬股。2020年6月5日至2020年12月4日,久立集團通過深圳證券交易所繫統增持公司股份291.95萬股,累計增持公司股份1133.49萬股,佔增持完成日(2020年12月4日)公司總股本的1.22%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.